In the wake of a recent safety scare in a confirmatory trial of its antibody-drug conjugate Zynlonta, ADC Therapeutics is tightening its belt in an effort to get the most out of its cancer med. On ...

Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.

Hyderabad-based infrastructure major Megha Engineering and Infrastructures Limited (MEIL) on Wednesday entered into a strategic partnership with global technology company Analog to deploy “Physical ...

The game is on for TROP2 antibody-drug conjugates in first-line triple-negative breast cancer. Less than a month after an approval for Daiichi Sankyo and AstraZeneca’s Datroway for front-line TNBC ...

Body mass index as a prognostic factor for trastuzumab deruxtecan efficacy in advanced breast cancer: A multicenter retrospective real-world analysis.

Alert Gedatolisib Combo Approved for Advanced Breast Cancer Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

Did you know that you can now use Windows Update to reinstall your current Windows 11 version without losing data? Yes, this new feature lets you reinstall your current Windows 11 version using ...

Integrin β6 is expressed in ~90% of NSCLC and correlates with poor prognosis, supporting development of a selective, rapidly internalizing ADC designed to reduce off-target integrin binding.

SHAREit is a popular application that allows you to easily transfer photos, videos, and files between iPhone, Android, and a Windows PC or Mac without an Internet connection. 2] Using Hotspot. The ...

We Talk About Menopause More Than Ever. We Treat It Less Hormone therapy usage dropped to 1.7% in 2023. Drs Rachel Rubin and Jewel Kling discuss this shocking decline and how primary care can close ...